# A Study With Pentasa in Patients With Active Crohn's Disease

> **NCT00862121** · PHASE3 · TERMINATED · sponsor: **Ferring Pharmaceuticals** · enrollment: 20 (actual)

## Conditions studied

- Crohn´s Disease

## Interventions

- **DRUG:** Pentasa
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00862121
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Terminated due to poor recruitment
- **Last updated:** 2012-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00862121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00862121, "A Study With Pentasa in Patients With Active Crohn's Disease". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00862121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*